Freudenberg Of Germany Eyes China For Medical Technology Growth
This article was originally published in PharmAsia News
Executive Summary
Germany's Freudenberg Group said China is a factor in its long-term focus on increasing its profits in the medical technology sector, primarily because of the projected longer life expectancy of its population.